CORONA, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that Watson’s senior management will provide an overview of the Company’s business at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2006 at 4:00 p.m. Pacific Standard Time.
This presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Web site at http://ir.watsonpharm.com. The webcast can also be accessed at the following URL:
http://equityconferences.jpmorgan.com
An archived version will be available for 90 days after the live presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watsonpharm.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO )
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.
CONTACT: Investors, Patty Eisenhaur of Watson Pharmaceuticals, Inc.,+1-951-493-5611
